IIBR leads na​tional efforts to counter any and all biological threats from intentional attacks as well as naturally-emerging diseases. Using a multi-disciplinary project strategy, combined with cutting edge technologies, we develop methods for the identification of various bio-threats; forensic investigation of bio-terror agents and pathogenesis mech​anisms; design of new strategies for vaccine development, as well as evaluation of novel modalities of therapeutics. IIBR biotechnology cGMP multi-product facility, is designed for the development and production of bio-pharmaceuticals and unique vaccines for national preparedness. ​